For the quarter ending 2025-12-31, SRXH made $2,807K in revenue. -$8,614K in net income. Net profit margin of -306.88%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net sales | 2,807 | -6,036 | 11,447 | 7,159 |
| Cost of goods sold | 1,753 | -3,898 | 8,028 | 4,776 |
| Gross profit | 1,054 | -2,138 | 3,419 | 2,383 |
| Selling, general and administrative | 4,844 | -4,345 | 18,151 | 3,471 |
| Impairment expense | - | - | 2,690 | - |
| Total operating expenses | 4,844 | -5,690 | 20,841 | 3,471 |
| Loss from continuing operations | -3,790 | 3,552 | -17,422 | -1,088 |
| Interest expense | - | 157 | - | - |
| Interest expense, net | 1,288 | - | - | - |
| Other income | - | - | - | 43 |
| Loss on extinguishment of debt | -3,064 | -179 | - | - |
| Interest income (expense), net | - | - | -975 | 83 |
| Change in fair value of digital assets | -464 | - | - | - |
| Bargain purchase gain | - | 1,290 | 1,693 | - |
| Other expense | 4 | - | - | - |
| Total other income | - | 954 | 16 | 126 |
| Total other expense, net | -4,820 | - | - | - |
| Net loss before income taxes | -8,610 | 4,506 | -16,688 | -962 |
| Income tax expense | 4 | - | 138 | 2 |
| Net loss from continuing operations | -8,614 | -2,160 | - | - |
| Deferred tax income (expense) | - | - | -1,693 | - |
| Loss from discontinued operations | - | -9,092 | - | - |
| Net loss | -8,614 | -14,454 | -15,133 | -964 |
| Foreign currency translation adjustment | - | - | -11,791 | - |
| Reclassification of aoci related to discontinued operations | - | 7,628 | - | - |
| Total comprehensive loss | - | -6,827 | -26,924 | - |
| Loss per share, basic | -0.26 | -0.51 | -0.74 | -0.37 |
| Loss per share, diluted | -0.26 | -0.51 | -0.74 | -0.37 |
| Weighted average number of shares outstanding, basic | 33,737,015 | -949,969 | 20,401,138 | 2,605,843 |
| Weighted average number of shares outstanding, diluted | 33,737,015 | -949,969 | 20,401,138 | 2,605,843 |
SRx Health Solutions, Inc. (SRXH)
SRx Health Solutions, Inc. (SRXH)